TimothyPFlaniganMD
Infectious Disease • Providence, RIHIV/AIDS Medicine
Professor of Medicine, Brown University
Dr. Flanigan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
164 Summit Ave
Fain Bldg., Suite E
Providence, RI 02906Phone+1 401-793-2928Fax+1 401-793-7401
Education & Training
University of Pennsylvania Health SystemResidency, Internal Medicine, 1983 - 1986
Weill Cornell MedicineClass of 1983
Certifications & Licensure
RI State Medical License 1991 - 2026
MA State Medical License 1991 - 2022
OH State Medical License 1987 - 1994
PA State Medical License 1985 - 1988- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- Fellow (FACP) American College of Physicians, 1996
- Top MD Consumers Checkbook
Clinical Trials
- Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings Start of enrollment: 2005 May 01
- Buprenorphine and Integrated HIV Care Evaluation Start of enrollment: 2005 Aug 01
Publications & Presentations
PubMed
- 521 citationsPredictors of COVID-19 severity: A literature review.Benjamin Gallo Marin, Ghazal Aghagoli, Katya Lavine, Lanbo Yang, Emily J. Siff
Reviews in Medical Virology. 2021-01-01 - 52 citationsComparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the AmericasCynthia Firnhaber, Laura M. Smeaton, Nasinuku Saukila, Timothy P. Flanigan, Raman R. Gangakhedkar
International Journal of Infectious Diseases. 2010-12-01 - 47 citationsSerious infectious complications of corticosteroid therapy for COPD.Peter M. Wiest, Timothy P. Flanigan, Robert A. Salata, David M. Shlaes, Michael Katzman
Chest. 1989-06-01
Press Mentions
Miriam Hospital Seeking Kids for Lyme Disease Vaccine TrialMay 24th, 2021- Masses Following CDC Health Guidelines 'Extremely Safe' to Attend, Expert SaysMarch 8th, 2021
- Violence, HIV Risks, and Polysubstance Use Among HIV-Positive People Who Inject Drugs in UkraineJanuary 1st, 2021
- Join now to see all
Grant Support
- Drug USER Resources CoreNational Institute On Drug Abuse2008–2011
- The Brown Initiative In HIV And AIDS Clinical Research For Minority CommunitiesNational Institute Of Mental Health2008–2011
- HIV And Other Infectious Consequences Of Substance AbuseNational Institute On Drug Abuse2001–2011
- Planning Grant FO Rthe Borwn Institute For Clinical And Translational ScienceNational Center For Research Resources2006
- Adult Therapeutic Clinical Trials Program For HIV/AIDSNational Institute Of Allergy And Infectious Diseases2000–2006
- Directly Observed Therapy(Dot) For TB And HIV In KenyaFogarty International Center2003–2005
- Neurocognitive Consequences Of HIV/AIDS In South IndiaNational Institute Of Mental Health2003–2004
- Directly Observed Haart For Active Substance AbusersNational Institute On Drug Abuse2000–2003
- Core--Drug USER ResourcesNational Institute On Drug Abuse2002
- Core--Women And AIDSNational Institute Of Allergy And Infectious Diseases1998–2001
- Viral Activation Transfusion StudyDivision Of Blood Diseases And Resources1995–2000
- Induction Of Anti-Hiv IGA In Rectum And Cervix Of WomenNational Institute Of Allergy And Infectious Diseases1994–1997
- Modulation Of In Vitro Cryptosporidium Parvum InfectionNational Institute Of Allergy And Infectious Diseases1991–1993
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
